Annual Working Capital
-$893.00 K
-$10.86 M-108.96%
01 December 2023
Summary:
Plus Therapeutics annual working capital is currently -$893.00 thousand, with the most recent change of -$10.86 million (-108.96%) on 01 December 2023. During the last 3 years, it has fallen by -$1.53 million (-240.41%). PSTV annual working capital is now -101.91% below its all-time high of $46.86 million, reached on 31 December 2000.PSTV Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
-$6.75 M
+$2.66 M+28.27%
01 September 2024
Summary:
Plus Therapeutics quarterly working capital is currently -$6.75 million, with the most recent change of +$2.66 million (+28.27%) on 01 September 2024. Over the past year, it has dropped by -$5.86 million (-655.66%). PSTV quarterly working capital is now -114.76% below its all-time high of $45.73 million, reached on 31 December 2010.PSTV Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -655.7% |
| 3 y3 years | -240.4% | -153.5% |
| 5 y5 years | +88.7% | -186.1% |
PSTV Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -106.5% | at low | -139.3% | +28.3% |
| 5 y | 5 years | -106.5% | +88.7% | -139.3% | +28.3% |
| alltime | all time | -101.9% | +88.7% | -114.8% | +34.2% |
Plus Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$6.75 M(-28.3%) |
| June 2024 | - | -$9.41 M(+52.1%) |
| Mar 2024 | - | -$6.19 M(+592.7%) |
| Dec 2023 | -$893.00 K(-109.0%) | -$893.00 K(-185.4%) |
| Sept 2023 | - | $1.05 M(+8.4%) |
| June 2023 | - | $965.00 K(+15.8%) |
| Mar 2023 | - | $833.00 K(-91.6%) |
| Dec 2022 | $9.96 M(-28.1%) | $9.96 M(-26.0%) |
| Sept 2022 | - | $13.46 M(+12.9%) |
| June 2022 | - | $11.92 M(-30.6%) |
| Mar 2022 | - | $17.18 M(+24.0%) |
| Dec 2021 | $13.85 M(+2078.3%) | $13.85 M(+9.9%) |
| Sept 2021 | - | $12.61 M(+30.7%) |
| June 2021 | - | $9.65 M(+35.3%) |
| Mar 2021 | - | $7.13 M(+1021.2%) |
| Dec 2020 | $636.00 K(-88.1%) | $636.00 K(+159.6%) |
| Sept 2020 | - | $245.00 K(-76.0%) |
| June 2020 | - | $1.02 M(-62.3%) |
| Mar 2020 | - | $2.71 M(-49.3%) |
| Dec 2019 | $5.34 M(-167.5%) | $5.34 M(-31.9%) |
| Sept 2019 | - | $7.84 M(-190.5%) |
| June 2019 | - | -$8.66 M(-11.9%) |
| Mar 2019 | - | -$9.83 M(+24.3%) |
| Dec 2018 | -$7.91 M(+122.8%) | -$7.91 M(+14.7%) |
| Sept 2018 | - | -$6.90 M(-32.7%) |
| June 2018 | - | -$10.25 M(+43.6%) |
| Mar 2018 | - | -$7.14 M(+101.2%) |
| Dec 2017 | -$3.55 M(-156.8%) | -$3.55 M(-58.5%) |
| Sept 2017 | - | -$8.56 M(-457.6%) |
| June 2017 | - | $2.39 M(-400.4%) |
| Mar 2017 | - | -$797.00 K(-112.8%) |
| Dec 2016 | $6.25 M(-51.2%) | $6.25 M(-38.4%) |
| Sept 2016 | - | $10.14 M(-39.2%) |
| June 2016 | - | $16.67 M(+144.0%) |
| Mar 2016 | - | $6.83 M(-46.7%) |
| Dec 2015 | $12.81 M(+122.0%) | $12.81 M(-22.8%) |
| Sept 2015 | - | $16.58 M(-18.9%) |
| June 2015 | - | $20.44 M(+1663.2%) |
| Mar 2015 | - | $1.16 M(-79.9%) |
| Dec 2014 | $5.77 M(-40.3%) | $5.77 M(+3333.9%) |
| Sept 2014 | - | $168.00 K(-95.6%) |
| June 2014 | - | $3.81 M(-47.3%) |
| Mar 2014 | - | $7.23 M(-25.3%) |
| Dec 2013 | $9.67 M(-40.9%) | $9.67 M(+77.5%) |
| Sept 2013 | - | $5.45 M(-60.7%) |
| June 2013 | - | $13.88 M(+84.6%) |
| Mar 2013 | - | $7.52 M(-54.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $16.37 M(-53.9%) | $16.37 M(+98.7%) |
| Sept 2012 | - | $8.24 M(-57.9%) |
| June 2012 | - | $19.57 M(-33.4%) |
| Mar 2012 | - | $29.38 M(-17.3%) |
| Dec 2011 | $35.52 M(-22.3%) | $35.52 M(-13.8%) |
| Sept 2011 | - | $41.18 M(+65.9%) |
| June 2011 | - | $24.82 M(-27.6%) |
| Mar 2011 | - | $34.30 M(-25.0%) |
| Dec 2010 | $45.73 M(+361.2%) | $45.73 M(+70.5%) |
| Sept 2010 | - | $26.82 M(-26.7%) |
| June 2010 | - | $36.58 M(+67.7%) |
| Mar 2010 | - | $21.81 M(+120.0%) |
| Dec 2009 | $9.91 M(-1.7%) | $9.91 M(-12.8%) |
| Sept 2009 | - | $11.37 M(-4.0%) |
| June 2009 | - | $11.85 M(-7.5%) |
| Mar 2009 | - | $12.81 M(+26.9%) |
| Dec 2008 | $10.09 M(+142.1%) | $10.09 M(-9.2%) |
| Sept 2008 | - | $11.11 M(+1373.5%) |
| June 2008 | - | $754.00 K(-62.1%) |
| Mar 2008 | - | $1.99 M(-52.3%) |
| Dec 2007 | $4.17 M(-43.6%) | $4.17 M(-70.6%) |
| Sept 2007 | - | $14.16 M(-34.8%) |
| June 2007 | - | $21.71 M(+10.5%) |
| Mar 2007 | - | $19.64 M(+165.7%) |
| Dec 2006 | $7.39 M(-29.3%) | $7.39 M(-46.5%) |
| Sept 2006 | - | $13.81 M(+152.0%) |
| June 2006 | - | $5.48 M(-60.2%) |
| Mar 2006 | - | $13.77 M(+31.7%) |
| Dec 2005 | $10.46 M(-15.5%) | $10.46 M(+53.3%) |
| Sept 2005 | - | $6.82 M(-49.4%) |
| June 2005 | - | $13.48 M(+71.6%) |
| Mar 2005 | - | $7.86 M(-36.5%) |
| Dec 2004 | $12.38 M(-0.4%) | $12.38 M(-25.4%) |
| Sept 2004 | - | $16.60 M(-3.8%) |
| June 2004 | - | $17.25 M(+21.3%) |
| Mar 2004 | - | $14.22 M(+14.4%) |
| Dec 2003 | $12.43 M(-50.8%) | $12.43 M(-27.5%) |
| Sept 2003 | - | $17.14 M(-10.2%) |
| June 2003 | - | $19.09 M(-11.6%) |
| Mar 2003 | - | $21.59 M(-14.6%) |
| Dec 2002 | $25.28 M(-28.0%) | $25.28 M(-21.7%) |
| Sept 2002 | - | $32.30 M(+17.1%) |
| June 2002 | - | $27.58 M(-11.9%) |
| Mar 2002 | - | $31.30 M(-10.9%) |
| Dec 2001 | $35.12 M(-25.1%) | $35.12 M(-4.1%) |
| Sept 2001 | - | $36.63 M(-6.7%) |
| June 2001 | - | $39.26 M |
| Dec 2000 | $46.86 M | - |
FAQ
- What is Plus Therapeutics annual working capital?
- What is the all time high annual working capital for Plus Therapeutics?
- What is Plus Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Plus Therapeutics?
- What is Plus Therapeutics quarterly working capital year-on-year change?
What is Plus Therapeutics annual working capital?
The current annual working capital of PSTV is -$893.00 K
What is the all time high annual working capital for Plus Therapeutics?
Plus Therapeutics all-time high annual working capital is $46.86 M
What is Plus Therapeutics quarterly working capital?
The current quarterly working capital of PSTV is -$6.75 M
What is the all time high quarterly working capital for Plus Therapeutics?
Plus Therapeutics all-time high quarterly working capital is $45.73 M
What is Plus Therapeutics quarterly working capital year-on-year change?
Over the past year, PSTV quarterly working capital has changed by -$5.86 M (-655.66%)